(Q44070266)

29 November 2017

Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312055

12 September 2022

Lack of increase in heterozygous α1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150309

alpha-1-antitrypsin deficiency

2 December 2023

main subject

1 reference

1 reference

M. Rabinovitz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312055

12 September 2022

J. S. Gavaler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312055

12 September 2022

R. H. Kelly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312055

12 September 2022

M. Prieto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312055

12 September 2022

D. H. Van Thiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312055

12 September 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

full work available at URL

29 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840150309

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150309

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840150309

2 December 2023

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150309

2 December 2023

1 reference

29 November 2017

15

1 reference

29 November 2017

407-410

1 reference

29 November 2017

3

1 reference

Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).

29 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

NIH conference. Hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

Alpha 1-antitrypsin levels and phenotypes and hepatitis B serology in liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Liver disease in adults with alpha-1 -antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Cirrhosis and malignant hepatoma in alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Risk for liver disease in adults with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Alpha-1-antitrypsin: an ignored protein in understanding liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 Infants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Cirrhosis associated with partial deficiency of alpha-1-antitrypsin: A clinical and autopsy study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Alpha 1-antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

The genetics of alpha1-antitrypsin: a family study in England and Scotland.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

α-1-antitrypsin phenotypes in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Antitrypsin phenotypes in St. Louis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Alpha 1-antitrypsin deficiency and liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Changes in serum alpha1 antitrypsin, alpha1 acid glycoprotein and beta2 glycoprotein i in patients with malignant hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150309

7 January 2021

Natural History and Life Expectancy in Severe Alpha1-Antitrypsin Deficiency, Pi Z

5

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150309

2 December 2023

Identifiers

1 reference

29 November 2017

1 reference